Blog

NEW YORK and BERLIN, Jan. 28, 2025 (GLOBE NEWSWIRE) — atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, today announced positive topline results from Beckley Psytech’s Phase 2a open-label study of BPL-003 in 12 patients with moderate to severe alcohol use disorder (AUD). BPL-003…

Vancouver, British Columbia–(Newsfile Corp. – January 24, 2025) – Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU) (“Entheon” or the “Company“) is pleased to announce that it has entered into a binding letter of intent (“LOI“) dated January 23, 2025 with 1000141080 Ontario Ltd. (“Mentis AI“), pursuant to which Entheon will acquire all of the issued and…

VANCOUVER, BC, Jan. 23, 2025 /PRNewswire/ – Numinus Wellness Inc. (“Numinus” or the “Company”) (TSX: NUMI) (OTCQX: NUMIF) (FSE: LR23), a mental healthcare company advancing traditional and innovative behavioral health treatments including safe, evidence-based psychedelic-assisted therapies, announces that Michael Tan has been appointed CEO of the Company, with Payton Nyquvest transitioning to the role of Executive Chair. Michael Tan has been appointed CEO of the…

Toronto, Ontario–(Newsfile Corp. – January 22, 2025) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) (“Red Light Holland” or the “Company“), an Ontario-based corporation engaged in the production, growth, and sale of functional mushrooms and mushroom home grow kits in North America and Europe, as well as a premium brand of psilocybin truffles in…